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ABSTRACT 
The efficient azidation of -keto esters and silyl enol ethers using a benziodoxole-derived azide transfer reagent is 
reported. The azidation of cyclic -keto esters could be achieved in up to quantitative yields in the absence of any 
catalyst. In the case of less reactive linear -keto esters and silyl enol ethers, complete conversion and good yields 
could be obtained by using a zinc catalyst. 
Azides are extremely useful functional groups in 
synthetic chemistry.1 They are easily reduced to amines, 
but are themselves non-basic. They consequently 
constitute ideal amine precursors in multi-step synthesis. 
Furthermore, cycloaddition of azides with alkynes, 
especially catalyzed by copper, has become the most 
impressive example of "Click" chemistry, as it is 
completely orthogonal to other functionalities and can run 
under mild conditions without the need to exclude oxygen 
or moisture. This reaction is now one of the most often 
used functionalization methods for biomolecules and 
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polymers.2 In this context, new methods to introduce 
azides, especially in complex molecules, are urgently 
needed. 
Most approaches to access azides are based on the use 
of nucleophilic sodium azide. In contrast, the introduction 
of azides onto nucleophiles is much less developed. Such 
reactions would be especially useful to access -azido 
carbonyl compounds, which are important building 
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blocks in synthetic chemistry as precursors of amino acid 
derivatives.3 Sulfonyl azides have been most often used 
as electrophilic azide sources, but they work best for 
strongly nucleophilic lithium enolates.4 For the stabilized 
enolates derived from dicarbonyl compounds, a mixture 
of products resulting from competing diazo transfer and 
subsequent rearrangements has been observed.5 Another 
successful approach is based on the in situ Umpolung of 
either the azide or the enolate using a strong oxidant. 
These reactions often involve the formation of iodoazide 
or hypervalent iodine reagents, and have been usually 
proposed to proceed via a radical pathway.6 In the case of 
the azidation of dicarbonyl compounds, the most general 
protocol has been reported in 2012 by Kirsch and co-
workers based on the combination of sodium azide and 
IBX.6n In most oxidative methods, the actual azidation 
reagent is either unknown, or so unstable that it cannot be 
isolated. This makes the development of catalytic or 
asymmetric methods very difficult. In fact, until 2013, no 
catalytic asymmetric -azidation of carbonyl compounds 
had been reported, and the only method to access 
enantiopure products was based on a chiral auxiliary 
approach.4  
To solve this challenge, we decided to make use of the 
exceptional stability of benziodoxol(on)e-based 
hypervalent iodine reagents.7 Our group has recently 
demonstrated the exceptional properties of this class of 
reagents for acetylene transfer onto dicarbonyl 
compounds,8 and we wondered if similar azido reagents 
would be equally successful. In fact, Zhdankin and co-
workers have described the synthesis of azido 
benziodoxol(on)e compounds, which were surprisingly 
stable.9 The reactivity of these reagents was studied for 
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the radical-based azidation of aliphatic C-H bonds.9,10 
During completion of our work, Gade and co-workers 
reported the first catalytic asymmetric method for the 
azidation of -keto esters and oxindoles using a chiral 
iron catalyst together with an azidobenziodoxole 
reagent.11 This major breakthrough motivate us to report 
our own preliminary results in the area, including the very 
efficient azidation of cyclic -keto esters with 
azidobenziodoxole 2 in the absence of any catalyst and 
the zinc-catalyzed azidation of less reactive linear keto 
esters and silyl enol ethers using the same reagent 
(Scheme 1). Our results demonstrated that the potential of 
azidobenziodoxole reagents as electrophilic azidation 
reagents is not limited to cyclic -keto esters. 
 
Scheme 1. Azidation of Keto Esters and Silyl Enol Ethers 
 
 
We started our studies with the investigation of the 
azidation of keto ester 1a with benzidoxol(on)e reagents 2 
and 6. Whereas no reaction was observed with 
benziodoxolone 6, a complete conversion to azide 3a was 
observed with benziodoxole 2 in different solvents, with 
the best yield (82% by 1H NMR) obtained in toluene.12 
The better result obtained with benziodoxole 2 is 
probably due to the higher basicity of the alcoholate 
generated after azide transfer. 
 
Scheme 2. Azidation of Keto Ester 1a. 
 
 
With this extremely simple protocol for the azidation 
of keto esters in hand, we shortly investigated the scope 
of the reaction (Table 1). On a 0.40 mmol scale, azide 3a 
could be isolated in 94% yield (entry 1). The azidation 
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proceeded in good yields independent of the electronic 
properties of the substituent on the benzene ring of 
indanone (entries 2-4). More sterically hindered esters 
gave quantitative yields of azide (entries 5 and 6). 
Azidation of keto amide 1g was also possible in 67% 
yield (entry 7).13 Nevertheless, the reaction did not work 
for less reactive substrates, and no conversion was 
observed for both acyclic keto ester 1h (entry 8) or silyl 
enol ether 4a (entry 9). 
 
Table 1. Azidation of cyclic keto esters with benziodoxole 2. 
entry β-keto ester product yield(%)a 
1 
  
94 
2 
  
79 
3 
 
 
quant. 
4 
  
92 
5 
  
quant. 
6 
  
98 
7 
  
67 
8 
  
<5 
9 
  
<5 
aIsolated yields with keto ester 1 or enol ether 4a (0.40 mmol), 
benziodoxole 2 (0.52 mmol), toluene (0.4 mL), 1-3 h at rt. 
 
The low reactivity of 2 with silyl enol ethers is 
contrasting with the fast reaction reported for in situ 
generated non cyclic reagents.6c-h We wondered if the 
reactivity of the reagent could be further enhanced in the 
presence of a Lewis acid. In fact, several Lewis acids 
were able to catalyze the reaction of silyl enol ether 4a 
                                                     
(13) In the case of a tetralone-derived keto-ester, only a low yield 
(10%) of azidation was obtained, due to the formation of an aromatic 
product. A simple cyclopentanone could also be azidated in moderate 
yield (54%). See Supporting Information for further details. 
with benziodoxole 2 in toluene (Table 2). Moderate yields 
were obtained with Sc(OTf)3, Cu(OTf)2 and In(OTf)3 as 
catalysts (entries 1-3). The best results were obtained 
when using Sn(OTf)2, Hf(OTf)4•4H2O or Zn(OTf)2, 
which gave nearly identical yields (67-71%, entries 4-
6).When considering that zinc is cheap and non-toxic, we 
decided to continue with this metal as catalyst. Other zinc 
salts gave inferior results (entries 7-9). Triflic acid was 
also able to catalyze the reaction, but in only 28% yield 
(entry 10). Lower yields were also obtained in solvent 
different from toluene (entries 11-15). Finally, more 
sterically hindered silyl enol ethers 4b and 4c led to 
inferior results when compared to trimethylsilyl enol 
ether 4a (entries 16 and 17). We consequently decided to 
examine the scope of the reaction with trimethysilyl enol 
ethers and zinc triflate as catalyst (Table 3, entries 1-9). 
 
Table 2. Optimization of the azidation of silyl enol ethers. 
 
entry R catalyst solvent yield(%)a 
1 Me (4a) Sc(OTf)3 toluene 23 
2 Me (4a) Cu(OTf)2 toluene 36 
3 Me (4a) In(OTf)3 toluene
 58 
4 Me (4a) Sn(OTf)2 toluene
 68 
5 Me (4a)) Hf(OTf)4•4H2O toluene
 71 
6 Me (4a) Zn(OTf)2 toluene
 67 
7 Me (4a) Zn(NTf2)2 toluene
 41 
8 Me (4a) Zn(OAc)2 toluene 22 
9 Me (4a) Zn(BF4)2 toluene 47 
10 Me (4a) HOTf toluene 28 
11 Me (4a)) Zn(OTf)2 CH3CN 53 
12 Me (4a) Zn(OTf)2 Et2O 52 
13 Me (4a) Zn(OTf)2 CH2Cl2 30 
14 Me (4a)) Zn(OTf)2 THF 26 
15 Me (4a)) Zn(OTf)2 
iPrOH 0 
16 Et (4b) Zn(OTf)2 toluene 44 
17 iPr (4c)) Zn(OTf)2 toluene 23 
a 4 (0.1 mmol), 2 (0.13 mmol), catalyst (15 mol %), solvent (2 mL); 
Yield obtained by 1H NMR using 1,3,5-trimethoxybenzene as standard.  
 
On a 0.40 mmol scale, the azidation worked for silyl 
enol ethers derived from indanone and tetralone (Table 3, 
entries 1 and 2). Complete conversion was achieved in a 
few hours. The reaction could also be applied to the 
synthesis of tertiary azides (entries 3 and 4). The silyl 
enol ethers of acetophenone derivatives also worked in 
the reaction (entries 5-8), giving access to both primary 
and secondary azides. The azidation also proceeded well 
in presence of a thiophene heterocycle (entry 9). 
At this point, we wondered if the zinc-catalyzed 
conditions could also be used to extend the scope of 
azidation for keto ester substrates. Indeed, acyclic keto 
ester 1h, which did not react in the presence of 
azidobenziodoxole 2 only, could be now azidated in 73% 
yield (Table 3, entry 10). The reaction was also successful 
for keto esters bearing a more functionalized benzene ring 
(entries 11 and 12) or a thiophene heterocycle (entry 13).  
Cyclic keto esters are a privileged class of substrates 
for the development of asymmetric reactions, as two-
points binding of a chiral catalyst can lead to good 
enantioselectivity. However, the high background rate 
observed with reagent 2 for cyclic keto esters constituted 
an important challenge for asymmetric induction. 
Nevertheless, an interesting preliminary result was 
obtained using a copper catalyst and bisoxazoline 7 as 
chiral ligand for the azidation of keto ester 1e with 49% 
ee (Scheme 3). The results of Gade and co-workers 
obtained simultaneously to our own investigations 
demonstrated the higher efficiency of a tridentate 
bisoxazoline ligand with iron as catalyst.11 
 
Table 3. Scope of the zinc-catalyzed azidation. 
entry indole product yield(%)a 
1 
  
58 
2 
  
58 
3 
  
62 
4 
  
55 
5 
  
73 
6 
  
72 
7 
  
82 
8 
  
75 
9 
  
81 
10 
  
73 
11 
  
58 
12 
  
55 
13 
  
64 
aIsolated yields with keto ester 1 or enol ether 4 (0.40 mmol), 
benziodoxole 2 (0.52 mmol), Zn(OTf)2 (0.060-0.12 mmol), toluene (0.8 
mL), 12 h at rt.  
 
 
 
Scheme 3. Enantioselective Azidation of Keto-Ester 1e. 
 
 
Several mechanisms can be envisaged for the azidation 
reaction. A first possibility is nucleophilic attack of either 
the oxygen or the carbon atom of the enolate on the 
iodine atom of benziodoxole 2, followed by C-N bond 
formation. A second alternative would involve a radical 
chain reaction, as has been proposed by Magnus and co-
workers.6c-h However, several observations make the 
latter less probable: in contrast to what was reported by 
Magnus and co-workers, no reaction was observed in the 
absence of catalyst. Furthermore, diazidation products 
resulting from radical pathways were not obtained, and 
the reaction did not require the presence of a bulky 
triisopropylsilyl group on the oxygen. Finally, the 
addition of TEMPO to the reaction mixture had no 
influence on the reaction outcome, neither with keto 
esters nor with silyl enol ethers. These results are 
consequently more in accordance with an electrophilic 
azidation, as has been proposed recently by Muniz and 
co-workers for the transfer of NTs group using an 
hypervalent iodine reagent.14 The role of the zinc catalyst 
is also intriguing, as it may act either through nucleophilic 
activation by formation of a zinc enolate, or by 
electrophilic activation of benziodoxole 2. Further 
investigations will be required to gain a better 
understanding of the reaction mechanism.  
In conclusion, we have described that the azidation of 
cyclic keto esters with benziodoxole reagent 2 proceeded 
in excellent yield in the absence of any catalyst. For less 
reactive acyclic keto esters and silyl enol ethers, an 
efficient zinc-catalyzed method could be developed, 
which gave access to primary, secondary and tertiary 
azides. Further extension of the scope of the reaction and 
development of asymmetric protocols not limited to 
                                                     
(14) Souto, J. A.; Martinez, C.; Velilla, I.; Muniz, K. Angew. Chem., 
Int. Ed. 2013, 52, 1324. 
cyclic keto esters are currently under investigation and the 
results will be reported in due course. 
Supporting Information. Experimental procedures 
and analytical data for all new compounds. This material 
is available free of charge via the Internet at 
http://pubs.acs.org. 
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1. General Methods 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, unless 
stated otherwise. For quantitative flash chromatography technical grade solvents were used. For 
flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, 
Et2O, CH3CN, toluene, hexane and CH2Cl2 were dried by passage over activated alumina under 
nitrogen atmosphere (H2O content < 10 ppm, Karl-Fischer titration). All chemicals were 
purchased from Acros, Aldrich, Fluka, VWR, Fluorochem, Aplichem or Merck and used without 
further purification, unless stated otherwise. Chromatographic purification was performed as 
flash chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as 
eluent with 0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC aluminium 
plates and visualized with UV light and anisaldehyde stain. Melting points were measured on a 
calibrated Büchi B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra 
were recorded on a Bruker DPX-400 400 MHz spectrometer in chloroform-d and/or DMSO-d6. 
All signals are reported in ppm with the internal chloroform signal at 7.26 ppm or the internal 
DMSO signal at 2.50 ppm as standard. The data is being reported as (s = singlet, d = doublet, t = 
triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, app = 
apparent, coupling constant(s) in Hz, integration, interpretation).13C-NMR spectra were recorded 
with 1H-decoupling on a Bruker DPX-400 100 MHz spectrometer in chloroform-d and/or 
DMSO-d6. All signals are reported in ppm with the internal chloroform signal at 77.0 ppm or the 
internal DMSO signal at 39.5 ppm as standard. Infrared spectra were recorded on a JASCO FT-
IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm-
1 (w = weak, m = medium, s = strong, br = broad). Gas chromatographic and low resolution 
mass spectrometric measurements were performed on a Perkin-Elmer Clarus 600 gas 
chromatographer and mass spectrometer using a Perkin-Elmer Elite fused silica column (length: 
30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass spectrometric 
measurements were performed by the mass spectrometry service of ISIC at the EPFL on a 
MICROMASS (ESI) Q-TOF Ultima API. Compound 7 was purchase from Aldritch. 
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2. Synthesis of Reagents 
2.1 Synthesis of 1-azido-3,3-dimethyl-3-(1H)-1,2-benziodoxole (2) 
1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (9) 
 
Following a reported procedure1 methyl 2-iodobenzoate (8) (12 mL, 76 mmol) was dissolved 
under N2 atmosphere in dry diethyl ether (400 mL) and then the solution was cooled down at 0 
°C with an ice bath. Methylmagnesium bromide (56.0 mL, 168 mmol, 2.20 equiv) was added 
dropwise and the reaction was stirred for 30 min at 0 °C. The reaction mixture was then allowed 
to warm to room temperature and it was further stirred for 2 h. The reaction was quenched with 
NH4Cl in an iced bath. The organic layer was separated and extracted with Et2O (3 x 100 mL), 
water (2 x 200 mL), brine (1 x 100 mL) and the combined organic layers were dried over MgSO4. 
The solvent was removed in vacuum.  
With no further purification the crude mixture was dissolved in CCl4 (7 mL) and tert-butyl 
hypochlorite (10 mL, 92 mmol, 1.2 equiv) and the reaction mixture was stirred at room 
temperature. After one hour a yellow precipitate was collected by filtration and washed with 
hexane (60 mL) to afford compound 9 (7.7 g, 26 mmol, 34% yield) as a yellow solid. 
1H NMR (400 MHz, CDCl3) δ 8.03 (dd, 1 H, J = 8.1, 1.1 Hz, CHAr), 7.55 (m, 2 H, CHAr), 7.17 
(dd, 1 H, J = 7.3, 1.7 Hz, CHAr), 1.55 (s, 6 H, (CH3)2).
 13C NMR (101 MHz, CDCl3) δ 149.5, 
131.0, 130.5, 128.4, 126.1, 114.7, 85.2, 29.2. IR νmax 3729 (w), 3626 (w), 2972 (w), 2924 (w), 
2362 (w), 2055 (w), 2018 (w), 1742 (w), 1564 (w), 1464 (w), 1439 (w), 1379 (w), 1378 (w), 
1366 (w), 1277 (w), 1276 (w), 1256 (w), 1181 (w), 1154 (m), 1112 (w), 1048 (w), 1003 (w), 982 
(w), 943 (m), 866 (m), 808 (w), 790 (w), 789 (w), 762 (s), 745 (w), 724 (w), 718 (w). NMR data 
correspond to the reported values.1 
1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (10) 
 
Following a reported procedure 1 1-Chloro-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (9) (2.60 
g, 8.77 mmol) was dissolved in dry acetonitrile (25 mL) under N2 atmosphere. The reaction flask 
was covered with aluminum foils and protected from light. Silver acetate (1.46 g, 8.77 mmol, 
1.00 equiv) was then added in one portion. The reaction mixture was stirred in the dark at room 
temperature for 16 h. Filtration over a Celite plug and evaporation of the solvent yielded 
compound 10 (2.6 g, 8.8 mmol, 93%) as a light brownish solid. 
1H NMR (400 MHz, CDCl3) δ 7.79 (dd, 1 H, J = 8.0, 1.3 Hz, CHAr), 7.47 (m, 2H, CHAr), 7.18 
(dd, 1 H, J = 7.2, 1.7 Hz, CHAr), 2.11 (s, 3 H, COCH3), 1.52 (s, 6 H, (CH3)2).
 13C NMR (101 
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MHz, CDCl3) δ 177.4, 149.4, 130.4, 130.0, 129.9, 126.2, 115.7, 84.6, 29.2, 21.5. IR νmax 3099 
(w), 3057 (w), 2975 (w), 2930 (w), 2930 (w), 2865 (w), 1740 (w), 1640 (s), 1588 (w), 1566 (w), 
1462 (w), 1438 (m), 1363 (s), 1294 (s), 1259 (m), 1158 (m), 1114 (w), 1047 (w), 1033 (w), 1009 
(w), 949 (m), 926 (w), 866 (w), 761 (s), 723 (w). NMR data correspond to the reported values.4 
1-Azido-3,3-dimethyl-3-(1H)-1,2-benziodoxole (2) 
 
Caution: This reaction should be carried out behind a safety shield! Following a reported 
procedure2 1-Acetoxy-1,3-dihydro-3,3-dimethyl-1,2-benziodoxole (10) (2.30 g, 7.18 mmol) was 
dissolved in dry CH2Cl2 (36 mL) under N2 atmosphere. The reaction was placed in an iced bath 
and trimethylsilylazide (0.954 mL, 7.18 mmol, 1.00 equiv) was added via syringe, followed by 
TMSOTf (0.065 mL, 0.36 mmol, 0.050 equiv). The reaction was stirred for 15 min then the ice 
bath was removed and the stirring was continued for 1 h. The solvent was evaporated and the 
solid obtained was washed with n-hexane (2 x 30 mL, HLPC purity) to afford 2 as a yellow 
crystalline solid (2.10 g, 7.18 mmol, 96%). 
1H NMR (400 MHz, CDCl3) δ 7.77 (d, 1 H, J = 8.0 Hz, CHAr), 7.55 (m, 2 H, CHAr), 7.23 (d, 1 
H, J = 7.2 Hz, CHAr), 1.53 (s, 7 H, (CH3)2. 13C NMR (101 MHz, CDCl3) δ 149.2, 130.9, 130.4, 
127.8, 126.8, 114.0, 83.2, 29.6. IR νmax 3254 (w), 3085 (w), 3051 (w), 2976 (w), 2928 (w), 2860 
(w), 2486 (w), 2026 (s), 1918 (w), 1764 (w), 1697 (w), 1651 (w), 1589 (w), 1562 (w), 1462 (m), 
1428 (m), 1380 (w), 1364 (w), 1312 (w), 1273 (w), 1248 (s), 1182 (w), 1151 (m), 1111 (m), 1031 
(w), 1004 (w), 943 (m), 910 (m), 880 (w), 863 (m). NMR data correspond to the reported values.2 
2.2 Synthesis of 1-azido-1,2-benziodoxole-3-(1H)-one (6) 
1-Hydroxy-1,2-benziodoxol-3-(1H)-one (12) 
 
Caution: reaction carried out behind a safety shield! Following a reported procedure,3 NaIO4 
(7.24 g, 33.8 mmol, 1.00 equiv) and 2-iodo benzoic acid (11) (8.00 g, 32.2 mmol, 1.00 equiv) 
were suspended in 30% (v:v) aq AcOH (48 mL) under air. The mixture was vigorously stirred 
and refluxed for 4 h. the reaction mixture was then diluted with cold water (180 mL) and allowed 
to cool to room temperature, protecting it from light. The mixture is then filtered and further 
washed with ice water and cold acetone, air dried in the dark overnight to give the pure 
compound 12 (8.14 g, 30.4 mmol, 94% ) as a colorless solid. 
1H NMR (400 MHz, (CD3)2SO) 8.02 (dd, J = 7.7, 1.4 Hz, 1 H, ArH), 7.97 (m, 1 H, ArH), 7.85 
(dd, J = 8.2, 0.7 Hz, 1 H, ArH), 7.71 (td, J = 7.6, 1.2 Hz, 1 H, ArH). 13C NMR (100 MHz, 
(CD3)2SO) 167.7, 134.5, 131.5, 131.1, 130.4, 126.3, 120.4. IR vmax 3083 (w), 3060 (w), 2867 (w), 
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2402 (w), 1601 (m), 1585 (m), 1564 (m), 1440 (m), 1338 (s), 1302 (m), 1148 (m), 1018 (w), 834 
(m), 798 (w), 740 (s), 694 (s), 674 (m), 649 (m). NMR data correspond to the reported values. 3 
1-Acetoxy-1,2-benziodoxol-3-(1H)-one (13) 
 
Following a reported procedure,4 compound 12 (3.00 g, 11.3 mmol, 1.00 equiv) was heated in 
Ac2O (10 mL) to reflux until the solution turned clear (without suspension). The mixture was 
then left to cool down and white crystals started to form. The crystallization was continued at -18 
°C. The crystal were then collected and dried overnight under high vacuum to give compound 13 
(3.06 g, 10.0 mmol, 86%).  
1H NMR (400 MHz, CDCl3) δ 8.25 (dd, 1 H, J = 7.6, 1.4 Hz, ArH), 8.00 (dd, 1 H, J = 8.3, 0.5 
Hz, ArH), 7.92 (dt, 1 H, J = 7.0, 1.7 Hz, ArH), 7.71 (td, 1 H, J = 7.6, 0.9 Hz, ArH), 2.25 (s, 3 H, 
COCH3). NMR data correspond to the reported values.
4 
Synthesis of 1-azido-1,2-benziodoxole-3-(1H)-one (6) 
 
Caution: reaction carried out behind a safety shield! Following a reported procedure,2 compound 
13 (1.00 g, 3.28 mmol, 1.00 equiv) was stirred in dry DCM (3 mL) then TMSN3 (0.66 mL, 4.9 
mmol, 1.5 equiv) was cautiously added. A catalytic amount of TMSOTf (3 µL, 0.02 mmol, 0.005 
equiv) was added last to the mixture which was then stirred for 30 minutes. The reaction mixture 
was then died in vacuo to give a yellow precipitate, which was washed a few times with hexanes 
to give compound 6 (0.70 g, 2.4 mmol, 74%) as a pure pale yellow crystal. 
1H NMR (400 MHz, CDCl3:CH3CN; 10:1) δ 8.17 (dd, 1 H, J = 7.5, 1.3 Hz, ArH), 7.93 (m, 2 H, 
ArH), 7.70 (m, 1 H, ArH). 13C NMR (101 MHz, CDCl3:CH3CN; 10:1) δ 166.2, 134.8, 131.8, 
130.4, 125.4, 116.6, 115.4. IR vmax 2049 (s), 1639 (s), 1565 (m), 1440 (w), 1347 (w), 1295 
(m).The analysis data for the characterization of 6 correspond to the ones reported in the 
literature. 2 
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3. Synthesis of starting materials  
General procedure for the synthesis of β-keto esters. 
Following a slightly modified procedure,5 a spatula of sodium tert-butoxide was added to a 
suspension of NaH (2.2 equiv) in dimethyl carbonate (5.0 equiv). The ketone (1 equiv) was then 
added carefully at 0 °C. The reaction was stirred at room temperature and followed by TLC 
(using the solvent mixture indicated below for the Rf value and UV or p-anisaldehyde for 
visualization). Then 1 M HCl was added until the pH of the solution became neutral or slightly 
acidic. The organic layers were collected and washed with brine (2 x 20 mL), dried over MgSO4 
and concentrated in vacuum. The crude product was purified by column chromatography, using 
the solvent indicated for the Rf value. 
Methyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1a) 
Starting from 5-methoxy-2,3-dihydro-1H-inden-1-one (1.0 g, 6.2 
mmol), methyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1a) (0.94 g, 4.2 mmol, 69 % yield) was obtained as a 
yellow solid. Rf 0.3 (pentane:ethyl acetate 3:2). 1H NMR (400 MHz, 
CDCl3) δ 7.70 (m, 1 H, CHAr), 6.92 (m, 2 H, CHAr), 3.89 (s, 3 H, 
OMe), 3.79 (s, 3 H, OMe), 3.72 (dd, 1 H, J = 8.2, 4.0 Hz, CH), 3.51 
(dd, 1 H, J = 17.3, 3.9 Hz, CH2), 3.31 (dd, 1 H, J = 17.3, 8.2 Hz, CH2).
 13C NMR (101 MHz, 
CDCl3) δ 197.5, 169.9, 165.9, 156.8, 128.4, 126.4, 116.0, 109.6, 55.8, 53.4, 52.8, 30.3. NMR data 
correspond to the reported values.6  
Methyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1b) 
Starting from 1-indanone (0.80 g, 6.0 mmol), methyl 1-oxo-2,3-dihydro-
1H-indene-2-carboxylate (1b) (0.77 g, 3.0 mmol, 73 % yield) was 
obtained as a yellow solid. Rf 0.2 (pentane:ethyl acetate 10:1). 1H NMR 
(400 MHz, CDCl3) δ 7.78 (d, 1 H, J = 7.7 Hz, ArH), 7.63 (dt, 1 H, J = 
4.0, 8.0 Hz, ArH), 7.50 (dd, 1 H, J = 7.7, 0.8 Hz, ArH), 7.40 (t, 1 H, J = 
8.0 Hz, ArH), 3.79 (s, 3 H), 3.74 (dd, 1 H, J = 8.3, 4.1 Hz, CH), 3.57 (dd, 
1 H, J = 17.3, 4.0 Hz, CH2), 3.38 (dd, 1 H, J = 17.3, 8.3 Hz, CH2). 13C NMR (101 MHz, CDCl3) 
δ 199.4, 169.6, 153.6, 135.5, 135.2, 127.9, 126.6, 124.8, 53.2, 52.8, 30.3. IR νmax 2954 (w), 1743 
(m), 1711 (s), 1654 (w), 1608 (w), 1572 (w), 1462 (w), 1439 (m), 1373 (w), 1329 (w), 1295 (w), 
1261 (m), 1210 (m), 1155 (m), 1125 (w), 1093 (w), 1040 (w), 1020 (w), 990 (m), 962 (w), 915 
(w), 850 (w). NMR data correspond to the reported values.7 
5-Fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1c) 
Starting from 5-fluoro-2,3-dihydro-1H-inden-1-one (0.70 g, 4.7 mmol), 
methyl 5-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1c) (0.80 
g, 4.0 mmol, 85 % yield) was obtained as an orangeish solid. Rf: 0.3 
(pentane:EtOAc 10:2). Mp: 55.9-60.7°C. 1H NMR (400 MHz, CDCl3) 
ratio ketone/enol 8/1: ketone δ 7.78 (dd, 1 H, J = 8.5, 5.3 Hz, CHAr), 
7.17 (dd, 1 H, J = 8.3, 0.7 Hz, , CHAr), 7.10 (td, 1 H, J = 8.6, 1.9 Hz, , 
CHAr),  3.80 (s, 3 H, OMe), 3.77 (dd, 1 H, J = 8.3, 4.0 Hz, CH), 3.57 (dd, 1 H, J = 17.5, 4.0 Hz, 
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CH2), 3.36 (dd, 1 H, J = 17.5, 8.2 Hz, CH2); enol δ 10.41 (m, 1 H, OH), 7.61 (dd, 1 H, J = 8.4, 
5.2 Hz, CHAr), 7.12 (td, 2 H, J = 8.6, 1.9 Hz, CHAr), 3.87 (s, 3 H, OMe), 3.53 (s, 2 H, CH2).
 13C 
NMR (101 MHz, CDCl3) ketone: δ 197.4, 169.3, 167.6 (d, J C-F = 258 Hz), 156.6 (d, J C-F = 11 
Hz), 131.6 (d, J C-F = 1 Hz), 127.1 (d, J C-F = 11 Hz), 116.3 (d, J C-F = 23 Hz), 113.3 (d, J C-F = 22 
Hz), 53.4, 52.9, 30.1. IR νmax 3075 (w), 3066 (w), 2955 (w), 1745 (s), 1716 (s), 1658 (w), 1618 
(m), 1596 (m), 1483 (w), 1449 (w), 1437 (w), 1370 (w), 1331 (m), 1303 (w), 1252 (s), 1230 (m), 
1197 (m), 1162 (m), 1134 (w), 1087 (m), 1018 (w), 990 (w), 963 (w), 937 (w), 874 (w), 861 (w), 
820 (w), 782 (w), 739 (w). HRMS (ESI) calcd for C11FH10O3
+ [M+H]+ 209.0608; found 
209.0607. 
Methyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1d) 
Starting from 6-chloro-2,3-dihydro-1H-inden-1-one (1.0 g, 6.0 
mmol), methyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate 
(1d) (0.51 g, 2.3 mmol, 38 % yield) was obtained as an orange solid. 
Rf: 0.3 (pentane:EtOAc 10:1). Mp: 119.4-124-6°C. 1H NMR (400 
MHz, CDCl3) ratio ketone/enol 0.7/ 1: ketone δ 7.74 (d, 1 H, J = 1.7 
Hz, CHAr), 7.59 (dd, 1 H, J = 8.2, 1.9 Hz, CHAr), 7.45 (d, 1 H, J = 
8.2 Hz, CHAr), 3.80 (s, 3 H, OMe), 3.78 (dd, 1 H, J = 8.4, 4.1 Hz, CH), 3.54 (dd, 1 H, J = 17.4, 
4.0 Hz, CH2), 3.35 (dd, 1 H, J = 17.4, 8.2 Hz, CH2); enol δ 10.26 (m, 1 H, OH), 7.62 (s, 1 H, 
CHAr), 7.39 (s, 2 H, CHAr), 3.86 (s, 3 H, OMe), 3.50 (s, 2 H, CH2). 13C NMR ketone: δ 198.1, 
169.1, 151.6, 138.6, 135.5, 133.1, 127.8, 124.5, 53.6, 53.0, 29.9. IR νmax 3372 (w), 3353 (w), 
3322 (w), 3307 (w), 3297 (w), 3285 (w), 3257 (w), 2953 (w), 1746 (w), 1719 (w), 1665 (s), 1619 
(m), 1618 (m), 1596 (m), 1572 (s), 1445 (s), 1395 (w), 1353 (m), 1307 (w), 1258 (s), 1239 (s), 
1211 (s), 1195 (m), 1164 (m), 1129 (s), 1106 (m), 1068 (w), 1004 (w), 911 (w), 899 (w), 885 (w), 
805 (w), 775 (m), 733 (w). HRMS (ESI) calcd for C11H9ClNaO3
+ [M+Na]+ 247.0132; found 
247.0132. 
Tert-butyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1e) 
Following a reported procedure,8 starting from 1-indanone (2.0 g, 15 
mmol), tert-butyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1e) (1.63 g, 
7.02 mmol, 46% yield) was obtained as a purple oil. Rf: 0.4 
(pentane:EtOAc 8:2). 1H NMR (400 MHz, CDCl3) δ 7.71 (d, 1 H, J = 7.7 
Hz, ArH), 7.57 (t, 1 H, J = 8 Hz, ArH), 7.45 (d, 1 H, J = 7.4 Hz, ArH), 7.34 
(t, 1 H, J = 7.1 Hz), 3.58 (dd, 1 H, J = 8.2, 4.0 Hz, CH), 3.46 (dd, 1 H, J = 
8.2, 4.0 Hz, CH2), 3.29 (dd, 1 H, J = 17.2, 8.2 Hz, CH2), 1.46 (s, 9 H, (CH3)3). 13C NMR (101 
MHz, CDCl3) δ 200.4, 168.7, 154.1, 135.9, 135.6, 128.1, 126.9, 124.9, 82.4, 54.8, 30.7, 28.4( 
3C). IR νmax 2979 (w), 2933 (w), 1734 (s), 1733 (s), 1713 (s), 1645 (w), 1627 (w), 1608 (w), 
1595 (w), 1574 (w), 1476 (w), 1464 (w), 1408 (w), 1393 (w), 1382 (w), 1369 (m), 1329 (w), 
1298 (w), 1291 (w), 1270 (w), 1254 (w), 1226 (w), 1211 (w), 1149 (s), 1131 (m), 1092 (w), 1022 
(w), 1014 (w), 989 (w), 845 (w), 773 (w), 759 (w), 740 (m), 723 (m), 680 (w), 669 (w), 642 (w), 
630 (w). NMR data correspond to the reported values.8 
Adamantan-1-yl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1f) 
Following a reported procedure,9 starting from methyl 1-oxo-2,3-
dihydro-1H-indene-2-carboxylate (1.0 g, 5.0 mmol, 1.0 equiv), 
adamantan-1-yl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1f) 
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(788 mg, 2.54 mmol, 48%) was obtained as a pink powder. Rf: 0.6 (pentane:EtOAc 4:1). 1H 
NMR (400 MHz, CDCl3) δ 7.74 (d, 1 H, J = 7.6 Hz, ArH), 7.58 (t, 1 H, J = 6.9 Hz, ArH), 7.47 
(d, 1 H, J = 7.6 Hz, ArH), 7.36 (t, 1 H, J = 8, 12 Hz, ArH), 3.59 (dd, 1 H, J = 8.2, 3.9 Hz, CH), 
3.47 (m, 1 H, CH2), 3.31 (dd, 1 H, J = 17.2, 8.2 Hz, CH2), 2.13 (m, 12 H, CH2), 1.64 (m, 3 H, 
CH). 13C NMR (101 MHz, CDCl3) δ 200.1, 168.0, 153.7, 135.5, 135.2, 127.7, 126.5, 124.6, 82.2, 
54.6, 41.3 (3C), 36.2 (3C), 30.9 (3C), 30.4. IR νmax 2913 (s), 2854 (w), 1712 (s), 1640 (w), 1599 
(w), 1571 (w), 1519 (w), 1495 (w), 1460 (w), 1383 (w), 1351 (w), 1330 (w), 1291 (w), 1259 (m), 
1210 (m), 1189 (w), 1159 (w), 1130 (w), 1095 (w), 1056 (m), 1017 (w), 990 (w), 968 (w), 937 
(w), 910 (w), 862 (w), 861 (w), 816 (w). NMR data correspond to the reported values, except the 
peak at 30.9 in the 13C spectrum (reported as 32.9).9 
N-(4-fluorophenyl)-1-oxo-2,3-dihydro-1H-indene-2-carboxamide (1g) 
Following a slightly modified procedure,10 Starting from methyl 1-
oxo-2,3-dihydro-1H-indene-2-carboxylate (1.0 g, 5.0 mmol, 1.0 
equiv), N-(4-fluorophenyl)-1-oxo-2,3-dihydro-1H-indene-2-
carboxamide (1g) (515 mg, 1.91 mmol, 36%) was obtained as a 
pink powder. Rf: 0.63 (pentane:EtOAc 1:1). 1H NMR (400 MHz, 
CDCl3) δ 9.09 (s, 1 H,NH), 7.73 (d, 1 H, J = 7.7 Hz, ArH), 7.60 
(td, 1 H, J = 7.6, 1.1 Hz, ArH), 7.49 (m, 3 H, ArH), 7.35 (t, 1 H, J 
= 8 Hz, ArH), 6.96 (m, 2 H, ArH), 3.79 (dd, 1 H, J = 17.7, 4.1 Hz, CH), 3.67 (dd, 1 H, J = 8.3, 
4.1 Hz, CH2), 3.38 (dd, 1 H, J = 17.8, 8.3 Hz, CH2). 13C NMR (101 MHz, CDCl3) δ 203.6, 164.4, 
159.4 (d, J C-F = 244 Hz), 154.2, 136.2, 135.2, 133.8 (d, J C-F = 2 Hz), 127.9, 126.8, 124.6, 121.7 
(d, J C-F = 8 Hz, 2C), 115.7 (d, J C-F = 23 Hz, 2C), 53.2, 28.5. IR νmax 3339 (w), 2980 (w), 2939 
(w), 2356 (w), 2355 (w), 2343 (w), 1717 (s), 1651 (m), 1607 (w), 1530 (s), 1515 (s), 1463 (w), 
1408 (m), 1380 (w), 1330 (w), 1276 (m), 1221 (m), 1164 (m), 1099 (w), 1040 (w), 1010 (w), 930 
(w), 838 (s). HRMS (ESI) calcd for C16H13NO2F
+ (M+H) 270.0930, found 270.0922. 
Methyl 2-methyl-3-oxo-3-phenylpropanoate (1h) 
Starting from propiophenone (0.800 mL, 5.96 mmol), methyl 2-methyl-
3-oxo-3-phenylpropanoate (1h) (0.917 g, 4.77 mmol, 80 % yield) (was 
obtained as a yellow liquid. Rf: 0.4 (pentane:EtOAc 4:1). 1H NMR (400 
MHz, CDCl3) δ 7.97 (m, 2 H, ArH), 7.58 (m, 1 H, ArH), 7.47 (m, 2 H, 
ArH), 4.41 (q, 1 H, J = 7.1 Hz, CH), 3.67 (s, 3 H, OMe), 1.49 (d, 3 H, J 
= 7.1 Hz, CHMe). 13C NMR (101 MHz, CDCl3) δ 195.9, 171.3, 135.8, 
133.6, 128.8 (2C), 128.6 (2C), 52.5, 48.1, 13.9. NMR data correspond to the reported 
values.11 
Methyl 2-methyl-3-oxo-3-(4-(trifluoromethyl)phenyl) propanoate (1i) 
Starting from 1-(4-(trifluoromethyl)phenyl)propan-1-one (0.70 g, 3.5 
mmol), methyl 2-methyl-3-oxo-3-(4-(trifluoromethyl)phenyl) 
propanoate (1i) (0.740 g, 2.84 mmol, 82 % yield) was obtained as a 
colorless liquid. Rf: 0.3 (pentane:EtOAc 1:1). 1H NMR (400 MHz, 
CDCl3) δ 8.08 (d, 2 H, J = 8.2 Hz, CHAr), 7.75 (d, 2 H, J = 8.2 Hz, 
CHAr), 4.40 (q, 1 H, J = 7.1 Hz, CH), 3.70 (s, 1 H, OMe), 1.52 (d, 2 H, J = 7.1 Hz, CH3. 13C 
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NMR (101 MHz, CDCl3) δ 194.8, 170.9, 138.5, 134.8 (q, J = 32 Hz), 128.9 (2C), 125.9 (q, J = 4 
Hz, 2C), 123.5 (q, J = 273 Hz), 52.7, 48.4, 13.6. IR νmax 2997 (w), 2957 (w), 1745 (m), 1696 (m), 
1582 (w), 1513 (w), 1456 (w), 1438 (w), 1411 (w), 1325 (s), 1223 (w), 1171 (s), 1132 (s), 1067 
(s), 1017 (w), 980 (w), 950 (w), 853 (m), 822 (w), 741 (w), 729 (w), 714 (w). NMR data 
correspond to the reported values.11 
3-(4-Bromophenyl)-2-methyl-3-oxopropanoate (1j) 
Starting from 1-(4-bromophenyl)propan-1-one (0.80 g, 6.0 mmol), 
methyl 3-(4-bromophenyl)-2-methyl-3-oxopropanoate (1j) (0.52 g, 1.9 
mmol, 41 % yield) was obtained as a colorless liquid. Rf: 0.4 
(pentane:EtOAc 1:1).  1H NMR (400 MHz, CDCl3) δ 7.84 (m, 2 H, 
CHAr), 7.62 (d, 2 H, J = 8.4 Hz, CHAr), 4.34 (q, 1 H, J = 7.0 Hz, 
CH), 3.68 (m, 3 H, OMe), 1.49 (d, 3 H, J = 7.0 Hz, CH3). 13C NMR 
(101 MHz, CDCl3) δ 194.7, 171.0, 134.5, 132.2 (2C), 130.1 (2C), 128.9, 52.7, 48.1, 13.7. NMR 
data correspond to the reported values.12 
Methyl 2-methyl-3-oxo-3-(thiophen-2-yl)propanoate (1k) 
Starting from 1-(thiophen-2-yl)propan-1-one (0.70 g, 4.9 mmol), methyl 
2-methyl-3-oxo-3-(thiophen-2-yl)propanoate (1k) (0.96 g, 4.8 mmol, 97 
% yield) was obtained as an orange liquid. Rf: 0.3 (pentane:EtOAc 3:2). 
1H NMR (400 MHz, CDCl3) δ 7.78 (m, 1 H, CHAr), 7.69 (dd, 1 H, J = 
4.9, 0.9 Hz, CHAr), 7.15 (m, 1 H, CHAr), 4.26 (q, 1 H, J = 7.1 Hz, 
CH), 3.71 (s, 3 H, OMe), 1.51 (d, 3 H, J = 7.1 Hz, CH3). 13C NMR (101 
MHz, CDCl3) δ 188.5, 170.9, 143.0, 134.8, 132.9, 128.4, 52.7, 49.3, 14.0. NMR data correspond 
to the reported values.11 
 
Tert-butyl 1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (15) 
 
Compound 15 was synthetized following a reported procedure.8 α-tetralone (13) (1.0 g, 6.8 
mmol) in dry THF (5 mL) was added to a suspension of NaH (0.547 mg, 13.7 mmol, 2.00 equiv, 
60% dispersion in mineral oil) in dry THF (25 mL) at rt. The solution was warmed to reflux and 
tert butyl pyrrole-1-carboxylate (14) (2.29 g, 13.7 mmol, 2.00 equiv) in dry THF (3 mL) was 
added dropwise and the solution was stirred at reflux until completion as indicated by TLC. After 
cooling to 0 °C, the solution was acidified with 1 N HCl. The solution was extracted with EtOAc 
(30 mL) and the organic layer was washed with brine (30 mL), dried (Na2SO4) and concentrated 
under reduced pressure. The residue was purified by flash silica gel chromatography (Rf: 0.3; 6:4 
Pentane/ethylacetate). 
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1H NMR (400 MHz, CDCl3) enol δ 12.65 (s, 1 H, enol H), 7.81 (dd, J = 
7.5, 1.6 Hz, 1 H, Ar H), 7.31 (td, J = 7.2, 1.7 Hz, 2 H, Ar H), 7.18 (ddd, J = 
6.6, 1.9, 1.0 Hz, 1 H, Ar H), 2.81 (dd, J = 8.8, 6.7 Hz, 2 H, CH2), 2.56 – 
2.51 (m, 2H, CH2), 1.57 (s, 9 H, tBu). ketone: δ 8.07 (dd, J = 7.9, 1.4 Hz, 1 
H, Ar H), 7.51 (td, J = 7.5, 1.5 Hz, 1 H, Ar H), 7.31 (td, J = 7.2, 1.7 Hz, 1 
H, Ar H), 7.28 (m, 1 H, Ar H), 3.52 (dd, J = 9.9, 4.7 Hz, 1 H, CH), 3.13 – 2.95 (m, 2 H, CH2), 
2.51 – 2.44 (m, 1 H, CH2), 2.36 (ddt, J = 13.5, 6.2, 4.8 Hz, 1 H, CH2), 1.50 (s, 9 H, tBu). 
NMR data correspond to the reported values.13 
Methyl 2-oxocyclopentane-1-carboxylate (17) 
 
Compound 17 was synthesized following a reported procedure.5 In a 50 mL flask, NaH (1.05 g, 
26.2 mmol, 2.2 equiv) was suspended in THF (12 mL). Dimethyl carbonate (5.00 mL, 59.4 
mmol, 5.00 equiv) was added to the mixture together with a catalytic amount of potassium tert-
butoxide (67 mg, 0.59 mmol, 0.050 equiv). The solution was stirred for 1-2 minutes and then 
cyclopentanone (16) (1.0 g, 12 mmol) was added dropwise. The reaction was stirred at room 
temperature for 5 h. Water was then added carefully to quench the reaction. The aqueous layer 
was washed with Et2O (2 x 50 mL) and ethylacetate (2 x 50 mL). The organic layers were 
collected and washed with brine (2 x 50 mL). The solvent was evaporated under reduced pressure 
and the crude product was purified by flash chromatography (95:5 Pentane/ethylacetate) to give 
compound 17 (0.318 g, 2.24 mmol, 19%).  
1H NMR (400 MHz, CDCl3) δ 3.73 (s, 3 H, OMe), 3.16 (t, J = 9.0 Hz, 1 H, CH), 2.35 – 2.24 (m, 
4 H, CH2), 2.18 – 2.07 (m, 1 H, CH2), 1.93 – 1.78 (m, 1 H, CH2). 
NMR data correspond to the reported values.14 
 
Synthesis of silyl enol ethers 
Silyl enol ethers 4a-h are synthesized following reported procedures. 
((1H-Inden-3-yl)oxy)trimethylsilane (4a) 
Following a reported procedure,15 starting from 1-indanone (0.50 g, 3.8 mmol), 
((1H-inden-3-yl)oxy)trimethylsilane (4a) (0.69 g, 3.4 mmol, 90% yield) was 
obtained as a yellow liquid. 1H NMR δ 7.38 (m, 2 H, CHAr), 7.29 (m, 1 H, 
CHAr), 7.21 (m, 1 H, CHAr), 5.43 (t, 1 H, J = 2.4 Hz, CH), 3.27 (d, 2 H, J = 2.4 
Hz, CH2), 0.31 (m, 9 H, TMS). NMR data correspond to the reported values.
16 
((1H-Inden-3-yl)oxy)triethylsilane (4b) 
Starting from 1-indanone (0.50 g, 3.8 mmol), ((1H-inden-3-yl)oxy)triethylsilane 
(4b) (0.9 g, 3.8 mmol, 99% yield) was obtained as a colorless liquid. 1H NMR δ 
7.39 (m, 2 H, CHAr), 7.28 (m, 1 H, CHAr), 7.21 (m, 1 H, CHAr), 5.42 (t, 1 H, J 
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= 2.2 Hz, CH), 3.27 (d, 2 H, J = 2.1 Hz, CH2), 1.03 (t, 9 H, J = 8.0 Hz, CH2(CH3)3), 0.79 (q, 6 H, 
J = 7.7 Hz, CH2(CH3)3). NMR data correspond to the reported values.
17 
((1H-Inden-3-yl)oxy)triisopropylsilane (4c) 
Starting from 1-indanone (1.0 g, 7.6 mmol), ((1H-inden-3-
yl)oxy)triisopropylsilane (4b) (1.05 g, 3.64 mmol, 48% yield) was obtained as a 
colorless liquid. 1H NMR δ 7.42 (dd, 2 H, J = 19.5, 7.4 Hz, CHAr), 7.31 (t, 1 H, 
J = 7.3 Hz, CHAr), 7.22 (t, 1 H, J = 7.3 Hz, CHAr), 5.42 (t, 1 H, J = 2.1 Hz, 
CH), 3.27 (d, 2 H, J = 1.9 Hz, CH2), 1.34 (m, 3 H, TIPSCH), 1.15 (d, 18 H, J = 
7.4 Hz, TIPSCH3). NMR data correspond to the reported values.
18 
((3,4-Dihydronaphthalen-1-yl)oxy)trimethylsilane (4d) 
Starting from 1-tetralone (0.50 g, 3.4 mmol), ((3,4-dihydronaphthalen-1-
yl)oxy)trimethylsilane (4d) (0.74 g, 3.4 mmol, 99% yield) was obtained as a 
colorless liquid. 1H NMR δ 7.41 (m, 1 H, CHAr), 7.19 (dd, 1 H, J = 7.3, 1.6 
Hz, CHAr), 7.15 (td, 1 H, J = 7.4, 1.8 Hz, CHAr), 7.11 (m, 1 H, CHAr), 5.19 
(t, 1 H, J = 4.6 Hz, CH), 2.77 (t, 2 H, J = 7.8 Hz, CH2), 2.32 (m, 2 H, CH2), 
0.26 (m, 9 H, TMS). NMR data correspond to the reported values.19 
Trimethyl((2-methyl-1H-inden-3-yl)oxy)silane (4e) 
Starting from 2-methyl-2,3-dihydro-1H-inden-1-one (0.470 ml, 3.42 mmol),  
trimethyl((2-methyl-1H-inden-3-yl)oxy)silane (4e) (0.62 g, 3.1 mmol, 90% 
yield) was obtained as a colorless liquid. 1H NMR δ 7.31 (d, 1 H, J = 7.3 Hz, 
CHAr), 7.23 (d, 1 H, J = 7.3 Hz, CHAr), 7.18 (m, 1 H, CHAr), 7.12 (td, 1 H, J 
= 7.3, 1.2 Hz, CHAr), 3.19 (s, 2 H, CH2), 1.97 (s, 3 H, CH3), 0.27 (s, 9 H, 
TMS). NMR data correspond to the reported values.20 
Trimethyl((2-methyl-3,4-dihydronaphthalen-1-yl)oxy)silane (4f) 
Starting from 2-methyl-3,4-dihydronaphthalen-1(2H)-one (0.50 g, 3.1 mmol), 
trimethyl((2-methyl-3,4-dihydronaphthalen-1-yl)oxy)silane (4f) (0.38 g, 1.6 
mmol, 52% yield) was obtained as a colorless liquid. 1H NMR δ 7.31 (d, 1 H, 
J = 7.5 Hz, CHAr), 7.16 (m, 1 H, CHAr), 7.09 (m, 2 H, CHAr), 2.74 (t, 2 H, J 
= 7.8 Hz, CH2), 2.26 (t, 2 H, J = 8.0 Hz, CH2), 1.82 (s, 3 H, CH3), 0.21 (s, 9 H, 
TMS). NMR data correspond to the reported values.20 
Trimethyl((1-phenylvinyl)oxy)silane (4g) 
Starting from acetophenone (0.58 g, 4.8 mmol), trimethyl((1-
phenylvinyl)oxy)silane (4g) (0.86 g, 4.5 mmol, 93% yield) was obtained as a 
colorless liquid. 1H NMR δ 7.60 (m, 2 H, CHAr), 7.32 (m, 3 H, CHAr), 4.92 
(d, 1 H, J = 1.6 Hz, CH2), 4.43 (d, 1 H, J = 1.6 Hz, CH2), 0.27 (s, 9 H, TMS). 
NMR data correspond to the reported values.21 
(Z)-Trimethyl((1-phenylprop-1-en-1-yl)oxy)silane (4h) 
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Starting from propiophenone (0.53 g, 4.0 mmol), (Z)-trimethyl((1-phenylprop-
1-en-1-yl)oxy)silane (4h) (1.05 g, 5.10 mmol, 85% yield) was obtained as a 
colorless liquid. 1H NMR δ 7.46 (m, 2 H, CHAr), 7.29 (m, 2 H, CHAr), 7.23 
(d, 1 H, J = 7.1 Hz, CHAr), 5.33 (q, 1 H, J = 6.9 Hz, CH), 1.74 (d, 3 H, J = 6.9 
Hz, CH3), 0.14 (s, 9 H, TMS). NMR data correspond to the reported values.
21 
 
General procedure for the synthesis of silyl enol ethers. 
The ketone (1.00 equiv) dissolved in anhydrous THF (0.33 M in ketone) was added in an oven-
dried flask sealed with a septum and under N2 atmosphere. The solution was cooled down to 0 °C 
and a 2 M solution of NaHMDS (1.22 eq) or freshly prepared LDA (1.05 equiv) was added 
dropwise. The cold bath is removed and the yellow solution was stirred for 1 hour at room 
temperature. The reaction was cooled again at 0 °C and trimethyl silyl chloride (1.20 eq) was 
added dropwise. The reaction was stirred at room temperature for 5 hours after what the solvent 
was directly removed under reduced pressure. The resulting oil was purified by plug or by 
column chromatography on silica using the solvent indicated for the Rf value. 
(Z)-((1-(4-Bromophenyl)prop-1-en-1-yl)oxy)trimethylsilane (4i) 
Starting from 1-(4-bromophenyl)propan-1-one (0.50 g, 2.4 mmol), (Z)-((1-
(4-bromophenyl)prop-1-en-1-yl)oxy)trimethylsilane (4i) (0.54 g, 1.9 mmol, 
81 % yield) was obtained as a yellow liquid. Rf: 0.2 (100% pentane). 1H 
NMR (400 MHz, CDCl3) δ 7.41 (m, 2 H, CHAr), 7.33 (m, 2 H, CHAr), 5.33 
(q, 1 H, J = 6.9 Hz, CCH), 1.73 (d, 3 H, J = 6.9 Hz, CH3), 0.14 (m, 9 H, 
(CH3)3). 13C NMR (101 MHz, CDCl3) δ 148.9, 138.2, 131.2 (2C), 126.8 
(2C), 121.1, 106.1, 11.8, 0.6 (3C). IR νmax 3061 (w), 3041 (w), 2960 (w), 2914 (w), 2859 (w), 
1652 (m), 1590 (w), 1446 (w), 1397 (w), 1379 (w), 1323 (m), 1251 (s), 1181 (w), 1118 (w), 1105 
(w), 1069 (s), 1009 (m), 972 (w), 878 (s), 846 (s), 821 (s), 795 (w), 759 (m), 721 (w), 704 (w). 
HRMS (APPI) calcd for C12H17
79BrOSi [M+] 284.0232; found 284.0240. 
(Z)-Trimethyl((1-(4-(trifluoromethyl)phenyl)prop-1-en-1-yl)oxy)silane (4j) 
Starting from 1-(4-(trifluoromethyl)phenyl)propan-1-one (0.50 g, 2.5 mmol), 
(Z)-trimethyl((1-(4-(trifluoromethyl)phenyl)prop-1-en-1-yl)oxy)silane (4j) 
(0.30 g, 1.2 mmol, 47 % yield) was obtained as a yellow liquid. Rf: 0.2 
(100% pentane). 1H NMR (400 MHz, CDCl3) δ 7.56 (m, 4 H, CHAr), 5.45 
(q, 1 H, J = 6.9 Hz, CCH), 1.77 (d, 3 H, J = 6.9 Hz, CH3), 0.16 (m, 9 H, 
(CH3)3). 13C NMR (101 MHz, CDCl3) δ 148.7, 142.6, 129.2 (q, JC-F = 32 
Hz), 125.2 (2C), 125.1 (q, JC-F = 4 Hz, 2C), 124.3 (q, J = 272 Hz), 107.7, 11.8, 0.6 (3C). IR νmax 
3067 (w), 3052 (w), 2962 (w), 2918 (w), 2863 (w), 1651 (w), 1618 (w), 1448 (w), 1411 (w), 
1381 (w), 1290 (w), 1255 (m), 1167 (m), 1124 (s), 1113 (s), 1067 (s), 972 (w), 957 (w), 877 (s), 
844 (s), 797 (m), 758 (m), 704 (w). HRMS (APPI) calcd for C13H17F3OSi [M+] 274.1001; found 
274.1009. 
(Z)-Trimethyl((1-(thiophen-2-yl)prop-1-en-1-yl)oxy)silane (4k) 
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Starting from 1-(thiophen-2-yl)propan-1-one (0.50 mL, 4.0 mmol) (1k) (Z)-
trimethyl((1-(thiophen-2-yl)prop-1-en-1-yl)oxy)silane (4k) (0.648 g, 3.05 mmol, 
76 % yield) was obtained as a yellow liquid. Rf: 0.3 (pentane:EtOAc 4:1). 1H 
NMR (400 MHz, CDCl3) δ 7.10 (dd, 1 H, J = 5.0, 1.1 Hz, CHAr), 7.02 (dd, 1 H, 
J = 3.6, 1.0 Hz, CHAr), 6.93 (dd, 1 H, J = 5.0, 3.6 Hz, CHAr), 5.32 (q, 1 H, J = 
6.9 Hz, CH), 1.71 (d, 3 H, J = 6.9 Hz, CH3), 0.22 (s, 9 H, TMS).
 13C NMR (101 
MHz, CDCl3) δ 144.3, 143.1, 126.4, 123.0, 122.0, 104.2, 11.0, 0.0 (3C). IR νmax 2961 (w), 2914 
(w), 2860 (w), 1650 (w), 1523 (w), 1437 (w), 1413 (w), 1382 (w), 1357 (w), 1326 (m), 1312 (w), 
1250 (s), 1215 (w), 1104 (w), 1062 (s), 1039 (m), 960 (w), 938 (w), 912 (w), 868 (s), 846 (s), 796 
(w), 755 (m), 738 (w), 705 (w). HRMS (ESI) calcd for C10H17OSSi
+ [M+H]+ 213.0764; found 
213.0762. 
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4. Azidation of -keto ester 
 
General procedure for the azidation of cyclic -keto esters. 
The cyclic -keto ester (0.40 mmol) was dissolved in a 2 mL essay tube in toluene (1 M in keto 
ester). The reaction was stirred for 1 minute before adding dimethyl azido benziodoxole 2 (0.52 
mmol, 1.3 equiv) in one portion. The reaction was followed by TLC (using the solvent indicated 
for the Rf value, visualization with UV or p-anisaldehyde stain) until complete consumption of 
the starting material (1-3 h). The crude mixture was purified by column chromatography using 
the solvent indicated for the Rf value. 
Methyl 2-azido-5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3a) 
Starting from methyl 5-methoxy-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1a) (0.089 g, 0.40 mmol), methyl 2-azido-5-methoxy-1-
oxo-2,3-dihydro-1H-indene-2-carboxylate (3a) (0.10 g, 0.38 mmol, 
94 % yield) was obtained as a yellow oil. Rf: 0.6 (DCM/Pentane 4:1). 
1H NMR (400 MHz, CDCl3) δ 7.72 (d, 1 H, J = 8.6 Hz, CHAr), 6.95 
(dd, 1 H, J = 8.6, 2.0 Hz, CHAr), 6.87 (s, 1 H, CHAr), 3.89 (s, 3 H, 
OMe), 3.77 (s, 3 H, OMe), 3.60 (d, 1 H, J = 17.4 Hz, CH2), 2.95 (d, 1 H, J = 17.4 Hz, CH2). 13C 
NMR (101 MHz, CDCl3) δ 195.2, 169.2, 166.8, 155.2, 127.5, 126.0, 116.7, 109.6, 70.6, 55.9, 
53.5, 38.5. IR νmax 2956 (w), 2844 (w), 2108 (m), 2108 (m), 1750 (m), 1710 (m), 1598 (s), 1493 
(w), 1447 (w), 1438 (w), 1342 (w), 1311 (m), 1265 (s), 1239 (m), 1198 (w), 1181 (w), 1151 (w), 
1099 (w), 1089 (m), 1053 (w), 1025 (w), 960 (w), 930 (w), 900 (w), 850 (w), 832 (w), 788 (w), 
751 (w). HRMS (ESI) calcd for C12H11N3O4
+ [M]+ 262.0828; found 262.0830. 
Methyl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3b) 
Starting from methyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1b) 
(0.077 g, 0.40 mmol), methyl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (3b) (0.074 g, 0.32 mmol, 79 % yield) was obtained as a yellow 
oil. Rf: 0.47 (hexanes:EtOAc 4:1). 1H NMR (400 MHz, CDCl3) δ 7.81 (dd, 
1 H, J = 7.7, 0.2 Hz, CHAr), 7.68 (m, 1 H, CHAr), 7.45 (m, 2 H, CHAr), 
3.79 (s, 3 H, OMe), 3.67 (d, 1 H, J = 17.4 Hz, CH2), 3.03 (d, 1 H, J = 17.4 
Hz, CH2). 13C NMR (101 MHz, CDCl3) δ 197.4, 169.0, 152.1, 136.6, 133.0, 128.5, 126.5, 125.6, 
70.2, 53.6, 38.5. IR νmax 2110 (s), 1749 (s), 1718 (s), 1607 (w), 1464 (w), 1432 (w), 1334 (w), 
1269 (s), 1233 (s), 1181 (m), 1088 (w), 1051 (s), 959 (m), 910 (m), 863 (w), 811 (w). HRMS 
(APPI) calcd for C11H10NO3
+ [M-N2+H]
+ 204.0655; found 204.0666.
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Methyl 2-azido-5-fluoro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3c) 
Starting from methyl 5-fluoro-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1c) (0.083 g, 0.40 mmol), methyl 2-azido-5-fluoro-1-oxo-
2,3-dihydro-1H-indene-2-carboxylate (3c) (0.1 g, 0.4 mmol, quant.) was 
obtained as a white crystalline solid. Mp 98.4-100.7°C. Rf: 0.6 
(DCM/pentane 4:1). 1H NMR (400 MHz, CDCl3) δ 7.84 (dd, 1 H, J = 
8.3, 5.3 Hz, CHAr), 7.16 (m, 2 H, CHAr), 3.81 (s, 3 H, OMe), 3.66 (d, 1 
H, J = 17.6 Hz, CH2), 3.02 (d, 1 H, J = 17.6 Hz, CH2).
 13C NMR (101 MHz, CDCl3) δ 195.5, 
168.7, 168.1 (d, J C-F = 260 Hz), 155.1 (d, J C-F = 11 Hz), 129.4 (d, J C-F = 2 Hz), 128.2 (d, J C-F = 
11 Hz), 117.0 (d, J C-F = 24 Hz), 113.4 (d, J C-F = 23 Hz), 70.4, 53.7, 38.4. IR νmax 2959 (w), 2109 
(s), 1753 (s), 1721 (s), 1484 (w), 1428 (w), 1336 (w), 1258 (s), 1199 (m), 1180 (m), 1133 (w), 
1053 (m), 961 (w), 905 (w), 863 (m), 833 (w), 788 (w), 739 (w). HRMS (ESI) calcd for 
C11FH9NO3
+ [M-N2+H]
+ 222.0561; found 222.0562. 
Methyl 2-azido-6-chloro-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3d) 
Starting from methyl 6-chloro-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (1d) (0.0916 g, 0.408 mmol), methyl 2-azido-6-chloro-1-
oxo-2,3-dihydro-1H-indene-2-carboxylate (3d) (0.10 g, 0.38 mmol, 92 
% yield) was obtained as a white solid. Mp 141.6-146.3°C. Rf: 0.66 
(DCM/pentane 4:1). 1H NMR (400 MHz, CDCl3) δ 7.77 (d, 1 H, J = 
1.5 Hz, CHAr), 7.63 (dd, 1 H, J = 8.2, 1.9 Hz, CHAr), 7.42 (d, 1 H, J = 
8.2 Hz, CHAr), 3.80 (s, 3 H, OMe), 3.63 (d, 1 H, J = 17.4 Hz, CH2), 3.00 (d, 1 H, J = 17.5 Hz, 
CH2). 13C NMR (101 MHz, CDCl3) δ 196.3, 168.5, 150.1, 136.5, 134.9, 134.5, 127.7, 125.3, 
70.6, 53.7, 38.2. IR νmax 2959 (w), 2107 (s), 1746 (s), 1720 (s), 1599 (w), 1470 (w), 1427 (m), 
1327 (w), 1290 (w), 1276 (m), 1251 (s), 1237 (s), 1200 (s), 1176 (m), 1129 (w), 1108 (w), 1053 
(m), 1035 (w), 955 (w), 939 (w), 908 (w), 881 (w), 832 (m), 791 (w), 741 (w), 713 (m). HRMS 
(ESI) calcd for C11ClH9NO3
+ [M-N2+H]
+ 238.0265; found 238.0280. 
Tert-butyl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3e) 
Starting from tert-butyl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate (1e) 
(0.094 g, 0.40 mmol), tert-butyl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-
carboxylate (3e) (0.11 g, 0.40 mmol, quant.) was obtained as a white solid. 
Rf: 0.70 (DCM/pentane 4:1). 1H NMR (400 MHz, CDCl3) δ 7.79 (d, 1 H, J 
= 7.7 Hz, CHAr), 7.65 (td, 1 H, J = 7.6, 1.1 Hz, CHAr), 7.43 (m, 2 H, 
CHAr), 3.62 (d, 1 H, J = 17.2 Hz, CH2), 2.98 (d, 1 H, J = 17.2 Hz, CH2), 
1.44 (s, 9 H, tBu). 13C NMR (101 MHz, CDCl3) δ 198.0, 167.3, 152.3, 136.3, 133.2, 128.3, 
126.4, 125.4, 84.5, 70.5, 38.5, 27.9 (3C). IR νmax 2981 (w), 2915 (w), 2856 (w), 2114 (s), 1741 
(s), 1716 (s), 1608 (w), 1591 (w), 1465 (w), 1428 (w), 1396 (w), 1371 (w), 1344 (w), 1263 (m), 
1248 (s), 1236 (s), 1216 (m), 1184 (m), 1152 (s), 1106 (w), 1091 (w), 1049 (m), 964 (w), 911 (s), 
878 (w), 864 (w), 839 (m), 809 (w), 792 (w), 733 (s). NMR data correspond to the reported 
values.22
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Adamantan-1-yl 2-azido-1-oxo-2,3-dihydro-1H-indene-2-carboxylate (3f) 
Starting from adamantan-1-yl 1-oxo-2,3-dihydro-1H-indene-2-carboxylate 
(1f) (0.125 g, 0.402 mmol), adamantan-1-yl 2-azido-1-oxo-2,3-dihydro-1H-
indene-2-carboxylate (3f) (0.14 g, 0.39 mmol, 98 % yield) was obtained as 
a colorless oil. Rf: 0.77 (DCM/pentane 4:1). 
1H NMR (400 MHz, CDCl3) δ 
7.79 (d, 1 H, J = 7.7 Hz, CHAr), 7.64 (td, 1 H, J = 7.6, 1.2 Hz, CHAr), 7.42 
(m, 2 H, CHAr), 3.62 (d, 1 H, J = 17.2 Hz, CH2), 2.97 (d, 1 H, J = 17.2 Hz, 
CH2), 2.13 (s, 3 H, AdCH), 2.05 (m, 6 H, AdCH2), 1.61 (m, 6 H, AdCH2). 13C NMR (101 MHz, 
CDCl3) δ 198.1, 166.9, 152.3, 136.2, 133.2, 128.3, 126.4, 125.4, 84.5, 70.5, 41.1 (3C), 38.6, 36.0 
(3C), 30.9 (3C). IR νmax 2915 (m), 2857 (w), 2115 (m), 1741 (s), 1718 (s), 1610 (w), 1463 (w), 
1428 (w), 1353 (w), 1321 (w), 1267 (m), 1234 (s), 1188 (m), 1157 (w), 1130 (w), 1105 (w), 1049 
(m), 964 (w), 910 (s), 877 (w), 865 (w), 837 (w), 808 (w), 733 (s). HRMS (APPI) calcd for 
C20H21NO3 [M-N2]
+ 323.1521; found 323.1514. 
2-Azido-N-(4-fluorophenyl)-1-oxo-2,3-dihydro-1H-indene-2-carboxamide (3g) 
Starting from N-(4-fluorophenyl)-1-oxo-2,3-dihydro-1H-indene-2-
carboxamide (1g) (0.11 g, 0.40 mmol), 2-azido-N-(4-fluorophenyl)-
1-oxo-2,3-dihydro-1H-indene-2-carboxamide (3g) (0.083 g, 0.27 
mmol, 67 % yield) was obtained as a white solid. Mp 133.3-
135.1°C. Rf: 0.43 (DCM/pentane 4:1). 1H NMR (400 MHz, CDCl3) 
δ 8.53 (s, 1 H, NH), 7.83 (d, 1 H, J = 7.7 Hz, CHAr), 7.71 (m, 1 H, 
CHAr), 7.52 (m, 3 H, CHAr), 7.46 (t, 1 H, J = 7.4 Hz, CHAr), 7.02 (m, 2 H, CHAr), 4.11 (d, 1 H, 
J = 17.4 Hz, CH2), 3.32 (d, 1 H, J = 17.4 Hz, CH2). 13C NMR (101 MHz, CDCl3) δ 198.0, 164.1, 
159.8 (d, J C-F = 245 Hz), 152.4, 137.0, 133.3, 132.9 (d, J = 2 Hz), 128.6, 126.5, 125.6, 122.0 (d, 
J = 8 Hz, 2C), 115.8 (d, J = 23 Hz, 2C), 73.2, 37.5. IR νmax 3384 (w), 3333 (w), 3075 (w), 2982 
(w), 2926 (w), 2113 (s), 1717 (s), 1679 (m), 1608 (m), 1591 (w), 1530 (s), 1509 (s), 1468 (m), 
1428 (w), 1409 (m), 1372 (w), 1325 (w), 1304 (m), 1277 (m), 1248 (m), 1214 (s), 1188 (w), 1156 
(m), 1102 (w), 1091 (w), 1046 (m), 1017 (w), 991 (w), 962 (w), 911 (s), 877 (w), 862 (w), 835 
(s), 813 (m), 793 (w), 733 (s). HRMS (ESI) calcd for C16FH12N4O2
+ [M+H]+ 311.0939; found 
311.0937. 
Tert-butyl 2-azido-1-oxo-1,2,3,4-tetrahydronaphthalene-2-carboxylate (18) and tert-butyl 1-
hydroxy-2-naphthoate (19) 
Starting from ketoester 15 (98 mg, 0.40 mmol), azide 18 (11 mg, 0.038 mmol, 10% yield) was 
obtained as a colorless oil. The major product was naphthol 19 (56 mg, 0.23 mmol, 57%), 
isolated as a colorless oil. 
Rf 0.33 (100:1 Pentane/ethylacetate).1H NMR (400 MHz, CDCl3) δ 8.07 
(dd, J = 7.9, 1.4 Hz, 1 H, Ar H), 7.52 (td, J = 7.5, 1.5 Hz, 1 H, Ar H), 7.38 – 
7.32 (m, 1 H, Ar H), 7.27 – 7.23 (m, 1 H, Ar H), 3.10 (ddd, J = 17.1, 8.8, 
4.8 Hz, 1 H, CH2), 2.99 – 2.89 (m, 1 H, CH2), 2.57 (ddd, J = 13.6, 8.8, 4.7 
Hz, 1 H, CH2), 2.17 (ddd, J = 13.8, 6.6, 4.8 Hz, 1 H, CH2), 1.47 (s, 9 H, 
tBu). 13C NMR (101 MHz, CDCl3) δ 190.0, 167.4, 143.3, 134.4, 130.3, 
128.7, 128.4, 127.2, 84.2, 71.0, 31.4, 27.9, 25.0. IR ν 2980 (w), 2934 (w), 2109 (s), 1740 (s), 
1683 (m), 1602 (w), 1479 (w), 1456 (w), 1371 (w), 1277 (m), 1237 (s), 1153 (s), 1069 (w), 
934 (w), 909 (m), 841 (w), 820 (w). NMR data correspond to the reported values.23 
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Rf 0.97 (100:1 Pentane/ethylacetate).1H NMR (400 MHz, CDCl3) δ 12.27 
(s, 1 H, OH), 8.40 (ddt, J = 8.4, 1.5, 0.8 Hz, 1 H, Ar H), 7.77 – 7.74 (m, 1 
H, Ar H), 7.72 (d, J = 8.8 Hz, 1 H, Ar H), 7.59 (ddd, J = 8.2, 6.9, 1.4 Hz, 1 
H, Ar H), 7.51 (ddd, J = 8.2, 6.9, 1.3 Hz, 1 H, Ar H), 7.25 (d, J = 8.6 Hz, 1 
H, Ar H), 1.65 (s, 9 H, tBu). NMR data correspond to the reported values.24 
Methyl 1-azido-2-oxocyclopentane-1-carboxylate (20) 
Starting from ketoester 17 (73 mg, 0.40 mmol), azide 20 (39.5 mg, 0.216 mmol, 54% yield) was 
obtained as a colorless oil.  
Rf 0.5 (6:4 Pentane/DCM). 1H NMR (400 MHz, CDCl3) δ 3.83 (s, 3 H, OMe), 2.52 
– 2.35 (m, 3 H, CH2), 2.16 – 1.92 (m, 3 H, CH2). 13C NMR (101 MHz, CDCl3) δ 
208.9, 169.0, 70.9, 53.4, 36.5, 34.2, 19.2. IR ν 2976 (w), 2959 (w), 2897 (w), 2159 
(w), 2111 (s), 1753 (s), 1739 (s), 1438 (w), 1404 (w), 1317 (w), 1270 (m), 1230 (s), 
1194 (w), 1162 (m), 1143 (m), 1127 (m), 1041 (w), 1004 (m), 961 (w), 917 (w), 844 
(w), 819 (w), 797 (w), 765 (w), 738 (w). 1H NMR data correspond to the reported 
values.25 
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5. Zinc-catalyzed azidation of linear β-keto esters. 
 
General procedure  
Zn(OTf)2 (0.021 g, 0.058 mmol, 0.030 equiv) was suspended in a 2 mL essay tube in toluene (0.5 
M). The linear -keto ester (1h-k) (0.40 mmol) was then added. The reaction mixture was stirred 
for one minute before adding in one portion the dimethyl azido benziodoxole 2 (0.15 g, 0.50 
mmol, 1.3 equiv). The reaction was stirred at room and followed by TLC (using the solvent 
indicated for the Rf value, visualization with UV or p-anisaldehyde stain) until complete 
consumption of the starting material (12-24 h). The crude mixture was purified by column 
chromatography, using the solvent indicated for the Rf value. 
Methyl 2-azido-2-methyl-3-oxo-3-phenylpropanoate (3h) 
Starting from methyl methyl 2-methyl-3-oxo-3-phenylpropanoate (0.078 
g, 0.406 mmol) (1h), methyl 2-azido-2-methyl-3-oxo-3-phenylpropanoate 
(0.069 g, 0.296 mmol, 73 % yield, > 95% pure by NMR) (3h) was 
obtained as a yellow oil. Rf: 0.3 (Pentane/ethyl acetate 10:1). 1H NMR 
(400 MHz, CDCl3) δ 7.97 (m, 2 H, CHAr), 7.57 (m, 1 H, CHAr), 7.45 (m, 
2 H, CHAr), 3.75 (s, 3 H, OMe), 1.82 (s, 3 H, CH3). 13C NMR (101 MHz, 
CDCl3) δ 190.9, 170.3, 133.8, 133.5, 129.4 (2C), 128.7 (2C), 71.1, 53.5, 20.3. IR νmax 3069 (w), 
3068 (w), 3007 (w), 2957 (w), 2111 (s), 1749 (s), 1696 (s), 1598 (w), 1582 (w), 1515 (w), 1450 
(m), 1411 (w), 1379 (w), 1355 (w), 1235 (s), 1189 (w), 1120 (s), 1062 (w), 1002 (w), 967 (m), 
912 (m), 864 (w), 799 (w), 786 (w), 733 (s). NMR data correspond to the reported values.26 
Methyl 2-azido-2-methyl-3-oxo-3-(4-(trifluoromethyl)phenyl)propanoate (3i) 
Starting from methyl 2-methyl-3-oxo-3-(4-(trifluoromethyl)phenyl) 
propanoate (1i) (0.103 g, 0.396 mmol), methyl 2-azido-2-methyl-3-
oxo-3-(4-(trifluoromethyl)phenyl)propanoate (3i) (0.069 g, 0.23 
mmol, 58% yield) was obtained as a yellow oil. Rf: 0.3 
(Pentane/diethyl ether 10:1). 1H NMR (400 MHz, CDCl3) δ 8.08 
(dd, 2 H, J = 8.9, 0.7 Hz, CHAr), 7.71 (d, 2 H, J = 8.3 Hz, CHAr), 
3.76 (s, 3 H, OMe3), 1.84 (s, 3 H, CH3). 13C NMR (101 MHz, CDCl3) δ 190.0, 170.1, 136.3, 
134.8 (q, JC-F = 32 Hz), 129.8 (2C), 125.7 (q, JC-F = 4 Hz, 2C), 123.4 (q, JC-F = 272 Hz), 71.0, 
53.7, 20.0. IR νmax 3081 (w), 3062 (w), 3011 (w), 2960 (w), 2849 (w), 2117 (m), 1752 (m), 1706 
(m), 1582 (w), 1514 (w), 1453 (w), 1440 (w), 1411 (w), 1380 (w), 1329 (s), 1246 (m), 1236 (m), 
1172 (s), 1119 (s), 1068 (s), 1018 (m), 972 (m), 912 (m), 854 (m), 795 (w), 767 (w), 736 (m), 711 
(w). HRMS (ESI) calcd for C12F3H11NO3
+ [M-N2+H]
+ 274.0686; found 274.0685.  
Methyl 2-azido-3-(4-bromophenyl)-2-methyl-3-oxopropanoate (3j) 
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Starting from methyl 3-(4-bromophenyl)-2-methyl-3-oxopropanoate 
(1j) (0.104 g, 0.385 mmol), methyl 2-azido-3-(4-bromophenyl)-2-
methyl-3-oxopropanoate (3j) (0.066 g, 0.21 mmol, 55% yield, > 95% 
pure by NMR) was obtained as a yellow oil. Rf: 0.3 (pentane:ethyl 
acetate 6:4). 1H NMR (400 MHz, CDCl3) δ 7.86 (m, 2 H, CHAr), 7.61 
(m, 2 H, CHAr), 3.77 (s, 3 H, OMe), 1.83 (s, 3 H, CH3). 13C NMR 
(101 MHz, CDCl3) δ 189.9, 170.2, 132.2, 132.0 (2C), 130.9 (2C), 129.2, 71.0, 53.6, 20.1. IR νmax 
3358 (w), 3343 (w), 3332 (w), 2120 (s), 1752 (w), 1698 (s), 1600 (m), 1534 (s), 1447 (m), 1413 
(w), 1377 (w), 1357 (w), 1327 (s), 1250 (s), 1174 (m), 1134 (s), 1069 (m), 1017 (w), 970 (w), 
911 (w), 857 (w), 758 (m), 743 (m). HRMS (APPI) calcd for C11
79BrH11NO3
+ [M-N2+H]
+ 
283.9917; found 283.9932.  
Methyl 2-azido-2-methyl-3-oxo-3-(thiophen-2-yl)propanoate (3k) 
Starting from methyl 2-methyl-3-oxo-3-(thiophen-2-yl)propanoate (1k) 
(0.079 g, 0.40 mmol), methyl 2-azido-2-methyl-3-oxo-3-(thiophen-2-
yl)propanoate (3k) (0.062 g, 0.26 mmol, 64% yield) was obtained as a 
yellow oil. Rf: 0.3 (pentane:ethyl acetate 6:4). 1H NMR (400 MHz, CDCl3) 
δ 7.88 (dd, 1 H, J = 3.9, 1.0 Hz, CHAr), 7.71 (dd, 1 H, J = 5.0, 1.0 Hz, 
CHAr), 7.13 (dd, 1 H, J = 4.9, 4.0 Hz, CHAr), 3.78 (s, 3 H, OMe), 1.80 (s, 
3 H, CH3). 13C NMR (101 MHz, CDCl3) δ 184.5, 169.7, 139.4, 135.5, 134.4, 128.5, 71.9, 53.6, 
20.5. IR νmax 3104 (w), 3006 (w), 2957 (w), 2110 (s), 1748 (s), 1673 (s), 1515 (w), 1452 (w), 
1436 (w), 1379 (w), 1265 (s), 1238 (s), 1118 (s), 1084 (w), 1061 (m), 975 (w), 925 (w), 863 (w), 
833 (w), 781 (w), 767 (m), 729 (s). HRMS (ESI) calcd for C9H10N3O3S
+ [M+H]+ 240.0437; 
found 240.0444. 
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6. Complete optimization table for silyl enol ether azidation. 
 
The Lewis Acid (15 mol %) was suspended in a test tube of 2 mL in toluene (0.05 M). Silyl 
enol ether 4a-c (0.1 mmol) was added and the reaction was stirred for 1 minute. Then 
dimethyl azido benziodoxole 2 (0.13 mmol, 1.3 equiv) was added in one portion. The reaction 
was followed by TLC (using the solvent indicated for the Rf value, visualization with UV or 
p-anisaldehyde stain) until disappearance of the starting material. 
Without further purification a sample of 0.2 mL was dried under high vacuum. A known 
amount of trimethoxybenzene (1.7 mg, 0.010 mmol, external standard) was added to the 
crude mixture. The yield was determined by 1HNMR analysis comparison with 1,3,5-
trimethoxybenzene peak at 6.2 ppm and the product peak at 4.32 ppm. 
Calibration curve with 1,3,5-trimethoxybenzene. 
 
Solvent and temperature optimization. 
Solvent 
With Zn(OTf)2 
Temperature 
 
1HNMR 
yields % 
Toluene rt 67 
Et2O rt 52 
CH3CN rt 53 
iPrOH rt 0 
DMF rt 10 
DMSO rt 30 
DCM rt 30 
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THF rt 26 
0°C 0°C 22 
Lewis acid optimization. 
Lewis Acid 
In toluene at r.t. 
1HNMR 
yields % 
Zn(OTf)2 67 
Sc(OTf)3 23 
Cu(OTf)2 36 
In(OTf)3 58 
Sn(OTf)2 68 
Yb(OTf)3 19 
AgOTf 25 
Hf(OTf)4 71 
AlCl3 0 
(CuOTf)2 Tol 38 
CuCl2 n.d 
SnCl4 30 
Zinc salts optimization. 
Zinc salts 
1HNMR 
yields % 
Zn(OTf)2 67% 
Zn(HNTf2)2 41% 
Zn(OAc)2 22% 
Zn(CF3CO2)2 26% 
Zn(BF4)2 47% 
ZnBr2 28% 
ZnCl2 18% 
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7. Zinc-catalyzed azidation of silyl enol ethers. 
 
General procedure 
Zn(OTf)2 (0.021 g, 0.058 mmol, 0.030 equiv) was suspended in a 2 mL essay tube in toluene (0.5 
M in silyl enol ether). The silyl enol ether (4a-k) (0.40 mmol) was then added. The reaction 
mixture was stirred for one minute before adding in one portion the dimethyl azido benziodoxole 
2 (0.15 g, 0.50 mmol, 1.3 equiv). The reaction mixture was stirred at room temperature and 
followed by TLC (using the solvent indicated for the Rf value, visualization with UV or p-
anisaldehyde stain) until complete consumption of the starting material (12-24 h). The crude was 
purified by column chromatography, using the solvent indicated for the Rf value. 
2-Azido-2,3-dihydro-1H-inden-1-one (5a) 
Starting from ((1H-inden-3-yl)oxy)trimethylsilane (4a) (0.0794 g, 0.389 
mmol), 2-azido-2,3-dihydro-1H-inden-1-one (5a) (0.0388 g, 0.224 mmol, 58% 
yield) was obtained as a yellow oil. Rf: 0.3 (Hexane/DCM 1:1). 1H NMR (400 
MHz, CDCl3) δ 7.80 (d, 1 H, J = 7.8 Hz, CHAr), 7.66 (td, 1 H, J = 7.6, 1.2 Hz, 
CHAr)), 7.44 (m, 2 H, CHAr)), 4.33 (dd, 1 H, J = 8.2, 4.7 Hz, CH), 3.51 (dd, 1 
H, J = 17.2, 8.3 Hz, CH2), 2.94 (dd, 1 H, J = 17.1, 4.6 Hz, CH3). 13C NMR 
(101 MHz, CDCl3) δ 201.8, 151.2, 136.1, 134.2, 128.3, 126.6, 124.7, 62.0, 33.0. IR νmax 2349 
(w), 2103 (s), 1721 (s), 1610 (m), 1609 (m), 1469 (w), 1432 (w), 1304 (w), 1303 (w), 1270 (m), 
1226 (m), 1225 (m), 1170 (w), 1158 (w), 1089 (w), 1088 (w), 1046 (m), 1037 (m), 1001 (m), 
1000 (m), 956 (w), 896 (w), 860 (w). NMR data correspond to the reported values.27 
2-Azido-3,4-dihydronaphthalen-1(2H)-one (5d) 
Starting from ((3,4-dihydronaphthalen-1-yl)oxy)trimethylsilane (4d) (0.0883 
g, 0.404 mmol), 2-azido-3,4-dihydronaphthalen-1(2H)-one (5d) (0.044 g, 0.24 
mmol, 58% yield) was obtained as a yellow oil. Rf: 0.3 (DCM/pentane 7:3). 1H 
NMR (400 MHz, CDCl3) δ 8.06 (dd, 1 H, J = 7.8, 1.2 Hz, CHAr), 7.52 (td, 1 
H, J = 7.5, 1.4 Hz, CHAr), 7.34 (m, 1 H, CHAr), 7.25 (m, 1 H, CHAr), 4.23 
(m, 1 H, CH), 3.07 (dd, 2 H, J = 7.7, 4.3 Hz, CH2), 2.37 (m,1H, CH2 ), 2.13 (m, 1 H, CH2). 13C 
NMR (101 MHz, CDCl3) δ 193.9, 143.4, 134.3, 131.1, 128.8, 128.0, 127.2, 64.4, 29.4, 27.6. IR 
νmax 2943 (w), 2873 (w), 2842 (w), 2101 (s), 1730 (w), 1692 (s), 1602 (m), 1481 (w), 1456 (w), 
1435 (w), 1357 (w), 1343 (w), 1314 (w), 1267 (m), 1227 (s), 1160 (w), 1114 (w), 1089 (w), 1026 
(w), 972 (w), 916 (m), 890 (w), 871 (w), 821 (w), 779 (w), 744 (s), 734 (s). NMR data 
correspond to the reported values.27 
2-Azido-2-methyl-2,3-dihydro-1H-inden-1-one (5e) 
Starting from trimethyl((2-methyl-1H-inden-3-yl)oxy)silane (4e) (0.0873 g, 
0.400 mmol), 2-azido-2-methyl-2,3-dihydro-1H-inden-1-one (5e) (0.046 g, 
0.25 mmol, 62% yield) was obtained as a yellow oil. Rf: 0.3 (DCM/pentane 
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3:2). 1H NMR (400 MHz, CDCl3) δ 7.80 (d, 1 H, J = 8.0 Hz, CHAr), 7.64 (td, 1 H, J = 7.5, 1.1 
Hz, CHAr), 7.41 (m, 2 H, CHAr), 3.13 (s, 2 H, CH2), 1.60 (s, 3 H, CH3). 13C NMR (101 MHz, 
CDCl3) δ 203.2, 150.8, 136.1, 133.5, 128.2, 126.6, 125.2, 65.3, 40.9, 21.2. IR νmax 2973 (w), 
2929 (w), 2102 (s), 1720 (s), 1609 (m), 1590 (w), 1467 (w), 1433 (w), 1375 (w), 1330 (w), 1304 
(w), 1287 (m), 1250 (m), 1217 (m), 1173 (w), 1134 (w), 1111 (w), 1092 (w), 1071 (w), 970 (m), 
913 (w), 875 (w), 796 (w), 739 (m). HRMS (ESI) calcd for C10H10NO
+ [M-N2+H]
+ 160.0757; 
found 160.0772. 
2-Azido-2-methyl-3,4-dihydronaphthalen-1(2H)-one (5f) 
Starting from trimethyl((2-methyl-3,4-dihydronaphthalen-1-yl)oxy)silane (4f) 
(0.0952 g, 0.410 mmol), 2-azido-2-methyl-3,4-dihydronaphthalen-1(2H)-one 
(5f) (0.045 g, 0.224 mmol, 55% yield) was obtained as a yellow oil. Rf: 0.5 
(Pentane/diethyl ether 10:1). 1H NMR (400 MHz, CDCl3) δ 8.02 (dd, 1 H, J = 
7.9, 1.0 Hz, CHAr), 7.45 (td, 1 H, J = 7.5, 1.4 Hz, CHAr), 7.28 (m, 1 H, CHAr), 
7.18 (d, 1 H, J = 7.7 Hz, CHAr), 3.08 (m, 1 H, CH2), 2.84 (m, 1 H, CH2), 2.15 
(m, 1 H, CH2), 2.02 (m, 1 H, CH2), 1.51 (s, 3 H, CH3). 13C NMR (101 MHz, CDCl3) δ 194.5, 
143.3, 134.0, 130.3, 128.7, 128.6, 127.1, 64.4, 34.9, 25.6, 20.3. IR νmax 2977 (w), 2933 (w), 2106 
(s), 1729 (w), 1685 (s), 1602 (m), 1485 (w), 1456 (m), 1434 (w), 1377 (w), 1358 (w), 1305 (m), 
1253 (m), 1229 (s), 1158 (w), 1129 (w), 1088 (w), 1042 (w), 1018 (w), 993 (w), 967 (m), 909 
(w), 896 (w), 875 (w), 800 (w), 778 (w), 705 (w). HRMS (ESI) calcd for C11H12NO
+ [M-N2+H]
+ 
174.0913; found 174.0911. 
2-Azido-1-phenylethanone (5g) 
Starting from trimethyl((1-phenylvinyl)oxy)silane (4g) (0.077 g, 0.40 mmol), 
2-azido-1-phenylethanone (5g) (0.047 g, 0.29 mmol, 73% yield) was obtained 
as a yellow oil. Rf: 0.3 (Pentane/diethyl ether 9:1). 1H NMR (400 MHz, 
CDCl3) δ 7.91 (m, 2 H, CHAr), 7.64 (m, 1 H, CHAr), 7.49 (m, 2 H, CHAr), 
4.56 (s, 2 H, CH2). 13C NMR (101 MHz, CDCl3) δ 193.2, 134.4, 134.2, 129.0 
(2C), 128.0 (2C), 54.9. NMR data correspond to the reported values.27 
2-Azido-1-phenylpropan-1-one (5h) 
Starting from (Z)-trimethyl((1-phenylprop-1-en-1-yl)oxy)silane (4h) (0.0662 g, 
0.321 mmol), 2-azido-1-phenylpropan-1-one (5h) (0.0405 g, 0.231 mmol, 72% 
yield) was obtained as a yellow oil. Rf: 0.3 (Pentane/ethyl acetate 10:1) 1H 
NMR (400 MHz, CDCl3) δ 7.94 (m, 2 H, CHAr), 7.62 (m, 1 H, CHAr), 7.50 
(t, 2 H, J = 7.9 Hz, CHAr), 4.71 (q, 1 H, J = 7.0 Hz, CHAr), 1.57 (d, 3 H, J = 
7.0 Hz, CH3). 13C NMR (101 MHz, CDCl3) δ 196.7, 134.3, 133.9, 128.9 (2C), 
128.7 (2C), 58.4, 16.5. NMR data correspond to the reported values.27 
2-Azido-1-(4-bromophenyl)propan-1-one (5i) 
Starting from (E)-((1-(4-bromophenyl)prop-1-en-1-yl)oxy)trimethylsilane 
(4i) (0.114 g, 0.400 mmol), 2-azido-1-(4-bromophenyl)propan-1-one (5i) 
(0.0833 g, 0.328 mmol, 82% yield) was obtained as a yellow oil. Rf: 0.3 
(Pentane/DCM 7:3). 1H NMR (400 MHz, CDCl3) δ 7.80 (m, 2 H, CHAr), 
7.63 (m, 2 H, CHAr), 4.63 (q, 1 H, J = 7.0 Hz, CHAr), 1.55 (d, 3 H, J = 
7.0 Hz, CH3) .13C NMR (101 MHz, CDCl3) δ 195.7, 133.0, 132.3 (2C), 130.2 (2C), 129.3, 58.4, 
16.3. IR νmax 2988 (w), 2987 (w), 2118 (m), 2102 (m), 1690 (m), 1569 (w), 1568 (w), 1486 (w), 
1452 (w), 1399 (w), 1379 (w), 1357 (w), 1277 (w), 1277 (w), 1251 (w), 1213 (m), 1181 (w), 
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1115 (w), 1102 (w), 1101 (w), 1073 (m), 964 (m), 911 (m), 840 (m), 777 (w), 733 (s). HRMS 
(APPI) calcd for C9H879BrNO [M-N2]+ 224.9784; found 224.9795. 
2-Azido-1-(4-(trifluoromethyl)phenyl)propan-1-one (5j) 
Starting from (E)-trimethyl((1-(4-(trifluoromethyl)phenyl)prop-1-en-1-
yl)oxy)silane (4j) (0.106 g, 0.386 mmol), 2-azido-1-(4-
(trifluoromethyl)phenyl)propan-1-one (5j) (0.0703 g, 0.289 mmol, 75% 
yield) was obtained as a yellow oil. Rf: 0.3 (Pentane/DCM 3:2). 1H NMR 
(400 MHz, CDCl3) δ 8.05 (d, 2 H, J = 8.2 Hz, CHAr), 7.76 (d, 2 H, J = 
8.4 Hz, CHAr), 4.70 (q, 1 H, J = 7.0 Hz, CH), 1.58 (d, 3 H, J = 7.0 Hz, CH3). 13C NMR (101 
MHz, CDCl3) δ 195.8, 137.1, 135.1 (q, JC-F = 33 Hz), 129.1 (2C), 126.0 (q, JC-F = 4 Hz, 2C), 
123.4 (q, JC-F = 273 Hz), 58.7, 16.0. IR νmax 2990 (w), 2121 (m), 2106 (m), 1789 (w), 1770 (w), 
1699 (m), 1581 (w), 1513 (w), 1452 (w), 1381 (w), 1324 (s), 1251 (w), 1217 (m), 1171 (m), 1131 
(s), 1068 (s), 1018 (m), 1000 (w), 967 (m), 913 (w), 855 (m), 791 (w), 767 (w), 739 (w), 707 (w). 
HRMS (ESI) calcd for C10F3H9NO
+ [M-N2+H]
+ 216.0631; found 216.0642. 
2-Azido-1-(thiophen-2-yl)propan-1-one (5k) 
Starting from (E)-trimethyl((1-(thiophen-2-yl)prop-1-en-1-yl)oxy)silane (4k) 
(0.0868 g, 0.409 mmol), 2-azido-1-(thiophen-2-yl)propan-1-one (5k) (0.060 g, 
0.33 mmol, 81% yield) was obtained as a yellow oil. Rf: 0.3 (Pentane/DCM 
6:4). 1H NMR (400 MHz, CDCl3) δ 7.79 (dd, 1 H, J = 4.0, 0.9 Hz, CHAr), 7.73 
(dd, 1 H, J = 4.7, 0.8 Hz, CHAr), 7.17 (dd, 1 H, J = 4.9, 4.0 Hz, CHAr), 4.52 (q, 
1 H, J = 7.0 Hz, CH), 1.60 (d, 3 H, J = 7.0 Hz, CH3). 13C NMR (101 MHz, CDCl3) δ 189.7, 
140.9, 135.2, 133.2, 128.5, 59.8, 17.0. IR νmax 3102 (w), 3093 (w), 2989 (w), 2109 (s), 1670 (s), 
1518 (w), 1450 (w), 1414 (s), 1378 (w), 1357 (w), 1323 (w), 1239 (s), 1223 (s), 1059 (m), 1043 
(w), 1013 (w), 999 (w), 917 (w), 862 (w), 848 (w), 832 (w), 777 (w), 730 (s). HRMS (ESI) calcd 
for C7H8NOS
+ [M-N2+H]
+ 154.0321; found 154.0325. 
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8. Enantioselective azidation of β-keto esters 
 
 
Preparation of the complex. 
CuCl2 (2.0 mg, 0.015 mmol, 1.0 equiv) and (+)-2,2′-Isopropylidenebis[(4R)-4-benzyl-2-
oxazoline] (5.3 mg, 0.015 mmol, 1.0 equiv) were stirred in a microwave tube of 2 mL in CH2Cl2 
(0.5 mL) for 2 h. Then the solution was transferred into another microwave tube where AgSbF6 
(10 mg, 0.030 mmol, 2.05 equiv) was previously placed. The reaction was stirred at room 
temperature for 5 h. The mixture was filtered and the solvent evaporated. The resulting complex 
was stored in a dry box and used as soon as possible. 
Enantioselective protocol. 
A solution of reagent 2 (15 mg, 0.055 mmol, 1.3 equiv) in toluene (0.43 mL, 0.1 M in 1e) was 
added in a microwave tube of 2 mL to the preformed complex (5.7 mg, 6.0 10-3 mmol, 0.014 
equiv) and the starting material 1e (10 mg, 0.043 mmol). The reaction was stirred at room 
temperature and followed by TLC (using the solvent indicated for the Rf value, visualization with 
UV or p-anisaldehyde stain) until disappearance of the starting material. 
The solvent was removed by evaporation and the crude product was purified by flash 
chromatography (DCM/pentane 4:1) and product 3e (0.056 g, 0.21 mmol, 51% yield).  
A small sample of pure compound was analyzed by chiral HPLC: (IC, Hexane/iPrOH = 99/1, 1 
mL/ min, 254nm), tR(major isomer)= 11.8 min, tR(minor isomer)= 13.3 min (49% ee). 
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